Biosergen AB (FRA:8N1) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biosergen AB's Free Cash Flow for the three months ended in Sep. 2024 was €-0.17 Mil. Biosergen AB's Revenue for the three months ended in Sep. 2024 was €0.00 Mil. Therefore, Biosergen AB's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Biosergen AB's current FCF Yield % is -16.66%.

The historical rank and industry rank for Biosergen AB's FCF Margin % or its related term are showing as below:

FRA:8N1's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -140.935
* Ranked among companies with meaningful FCF Margin % only.

Biosergen AB FCF Margin % Historical Data

The historical data trend for Biosergen AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB FCF Margin % Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Biosergen AB's FCF Margin %

For the Biotechnology subindustry, Biosergen AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosergen AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biosergen AB's FCF Margin % falls into.

Biosergen AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biosergen AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.928	/	0
	=	%

Biosergen AB's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-0.17	/	0
	=	%

Biosergen AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biosergen AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (FRA:8N1) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BIOSGN:Sweden

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines